{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:51:02Z","timestamp":1789861862313,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12185-014-1520-3","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T06:48:19Z","timestamp":1391064499000},"page":"227-239","source":"Crossref","is-referenced-by-count":55,"title":["Peripheral T cell lymphoma in Asia"],"prefix":"10.1007","volume":"99","author":[{"given":"Sanghui","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,31]]},"reference":[{"key":"1520_CR1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","volume":"9","author":"JR Anderson","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol. 1998;9:717\u201320.","journal-title":"Ann Oncol"},{"key":"1520_CR2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"1520_CR3","first-page":"396","volume":"43","author":"S Nakamura","year":"1993","unstructured":"Nakamura S, Koshikawa T, Koike K, Kitoh K, Suzuki H, Oyama A, et al. Phenotypic analysis of peripheral T cell lymphoma among the Japanese. Acta Pathol Jpn. 1993;43:396\u2013412.","journal-title":"Acta Pathol Jpn"},{"key":"1520_CR4","doi-asserted-by":"crossref","unstructured":"The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000;50:696\u2013702.","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"1520_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00277-009-0801-z","volume":"89","author":"R Ameen","year":"2010","unstructured":"Ameen R, Sajnani KP, Albassami A, Refaat S. Frequencies of non-Hodgkin\u2019s lymphoma subtypes in Kuwait: comparisons between different ethnic groups. Ann Hematol. 2010;89:179\u201384.","journal-title":"Ann Hematol"},{"key":"1520_CR6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3109\/10428194.2012.729056","volume":"54","author":"N Arora","year":"2013","unstructured":"Arora N, Manipadam MT, Nair S. Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature. Leuk Lymphoma. 2013;54:1004\u201311.","journal-title":"Leuk Lymphoma"},{"key":"1520_CR7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00277-003-0812-0","volume":"83","author":"A Isikdogan","year":"2004","unstructured":"Isikdogan A, Ayyildiz O, Buyukcelik A, Arslan A, Tiftik N, Buyukbayram H, et al. Non-Hodgkin\u2019s lymphoma in southeast Turkey: clinicopathologic features of 490 cases. Ann Hematol. 2004;83:265\u20139.","journal-title":"Ann Hematol"},{"key":"1520_CR8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4132\/KoreanJPathol.2011.45.3.254","volume":"45","author":"JM Kim","year":"2011","unstructured":"Kim JM, Ko YH, Lee SS, Huh J, Kang CS, Kim CW, et al. WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol AID. 2011;45:254\u201360. doi: 10.4132\/KoreanJPathol.45.3.254 .","journal-title":"Korean J Pathol AID"},{"key":"1520_CR9","first-page":"1703","volume":"90","author":"MY Lee","year":"2005","unstructured":"Lee MY, Tan TD, Feng AC, Liu MC. Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification. Haematologica. 2005;90:1703\u20135.","journal-title":"Haematologica"},{"key":"1520_CR10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bcmd.2004.08.001","volume":"33","author":"KN Naresh","year":"2004","unstructured":"Naresh KN, Advani S, Adde M, Aziz Z, Banavali S, Bhatia K, et al. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin\u2019s lymphoma in developing countries. Blood Cells Mol Dis. 2004;33:330\u20137.","journal-title":"Blood Cells Mol Dis"},{"key":"1520_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.humpath.2003.10.007","volume":"35","author":"S Sukpanichnant","year":"2004","unstructured":"Sukpanichnant S. Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol. 2004;35:224\u201330.","journal-title":"Hum Pathol"},{"key":"1520_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","volume":"6","author":"QP Yang","year":"2011","unstructured":"Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, et al. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol. 2011;6:77.","journal-title":"Diagn Pathol"},{"key":"1520_CR13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/0019-509X.92276","volume":"48","author":"RT Yaqo","year":"2011","unstructured":"Yaqo RT, Hughson MD, Sulayvani FK, Al-Allawi NA. Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification. Indian J Cancer. 2011;48:446\u201351.","journal-title":"Indian J Cancer"},{"key":"1520_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12185-008-0132-1","volume":"88","author":"SA Gross","year":"2008","unstructured":"Gross SA, Zhu X, Bao L, Ryder J, Le A, Chen Y, et al. A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol. 2008;88:165\u201373.","journal-title":"Int J Hematol"},{"key":"1520_CR15","first-page":"3055","volume":"12","author":"J Liu","year":"2011","unstructured":"Liu J, Song B, Fan T, Huang C, Xie C, Li J, et al. Pathological and clinical characteristics of 1,248 non-Hodgkin\u2019s lymphomas from a regional cancer hospital in Shandong, China. Asian Pac J Cancer Prev. 2011;12:3055\u201361.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1520_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.pai.0000176161.38402.b2","volume":"13","author":"J Wang","year":"2005","unstructured":"Wang J, Young L, Win W, Taylor CR. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique. Appl Immunohistochem Mol Morphol. 2005;13:323\u201332.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1520_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/10428190601043351","volume":"48","author":"CS Sahni","year":"2007","unstructured":"Sahni CS, Desai SB. Distribution and clinicopathologic characteristics of non-Hodgkin\u2019s lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000). Leuk Lymphoma. 2007;48:122\u201333.","journal-title":"Leuk Lymphoma"},{"key":"1520_CR18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood-2006-01-0394","volume":"108","author":"L Krenacs","year":"2006","unstructured":"Krenacs L, Schaerli P, Kis G, Bagdi E. Phenotype of neoplastic cells in angioimmunoblastic T-cell lymphoma is consistent with activated follicular B helper T cells. Blood. 2006;108:1110\u20131.","journal-title":"Blood"},{"key":"1520_CR19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","volume":"38","author":"D Baumjohann","year":"2013","unstructured":"Baumjohann D, Preite S, Reboldi A, Ronchi F, Ansel KM, Lanzavecchia A, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38:596\u2013605.","journal-title":"Immunity"},{"key":"1520_CR20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2009.03.003","volume":"30","author":"N Fazilleau","year":"2009","unstructured":"Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity. 2009;30:324\u201335.","journal-title":"Immunity"},{"key":"1520_CR21","first-page":"591","volume":"68","author":"G Pizzolo","year":"1983","unstructured":"Pizzolo G, Chilosi M, Fiore-Donati L, Perona G. Imbalance of peripheral blood and lymph node T cell subpopulations in angioimmunoblastic lymphadenopathy. Report of three cases. Haematologica. 1983;68:591\u20139.","journal-title":"Haematologica"},{"key":"1520_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.humpath.2011.02.024","volume":"43","author":"MR Steciuk","year":"2012","unstructured":"Steciuk MR, Massengill S, Banks PM. In immunocompromised patients, Epstein\u2013Barr virus lymphadenitis can mimic angioimmunoblastic T-cell lymphoma morphologically, immunophenotypically, and genetically: a case report and review of the literature. Hum Pathol. 2012;43:127\u201333.","journal-title":"Hum Pathol"},{"key":"1520_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prp.2009.03.005","volume":"206","author":"K Hatanaka","year":"2010","unstructured":"Hatanaka K, Nakamura N, Kojima M, Ando K, Irie S, Bunno M, et al. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract. 2010;206:9\u201313.","journal-title":"Pathol Res Pract"},{"key":"1520_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31:240\u20136.","journal-title":"J Clin Oncol"},{"key":"1520_CR25","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L Leval de","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109:4952\u201363.","journal-title":"Blood"},{"key":"1520_CR26","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","volume":"119","author":"RA Cairns","year":"2012","unstructured":"Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP, et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood. 2012;119:1901\u20133.","journal-title":"Blood"},{"key":"1520_CR27","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","volume":"120","author":"F Lemonnier","year":"2012","unstructured":"Lemonnier F, Couronne L, Parrens M, Jais JP, Travert M, Lamant L, et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood. 2012;120:1466\u20139.","journal-title":"Blood"},{"key":"1520_CR28","first-page":"306","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SA Pileri","year":"2008","unstructured":"Pileri SA, Weisenburger DD, Sng I, Jaffe ES, Ralfkiaer E, Nakamura S, et al. Peripheral T-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 306\u20138."},{"key":"1520_CR29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","volume":"32","author":"SM Rodriguez-Pinilla","year":"2008","unstructured":"Rodriguez-Pinilla SM, Atienza L, Murillo C, Perez-Rodriguez A, Montes-Moreno S, Roncador G, et al. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol. 2008;32:1787\u201399.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR30","doi-asserted-by":"crossref","unstructured":"Attygalle AD, Cabecadas J, Gaulard P, Jaffe ES, de Jong D, Ko YH, et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward\u2014report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014;64:171\u201399.","DOI":"10.1111\/his.12251"},{"key":"1520_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jcp.2010.084459","volume":"64","author":"HQ Zhan","year":"2011","unstructured":"Zhan HQ, Li XQ, Zhu XZ, Lu HF, Zhou XY, Chen Y. Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases. J Clin Pathol. 2011;64:319\u201324.","journal-title":"J Clin Pathol"},{"key":"1520_CR32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","volume":"33","author":"Y Huang","year":"2009","unstructured":"Huang Y, Moreau A, Dupuis J, Streubel B, Petit B, Le Gouill S, et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol. 2009;33:682\u201390.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia. 2006;20:313\u20138.","journal-title":"Leukemia"},{"key":"1520_CR34","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","volume":"37","author":"AD Attygalle","year":"2013","unstructured":"Attygalle AD, Feldman AL, Dogan A. ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2013;37:1456\u20137.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR35","first-page":"312","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"G Delsol","year":"2008","unstructured":"Delsol G, Falini B, Muller-Hermelink HK, Campo E. Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 312\u20136."},{"key":"1520_CR36","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111:5496\u2013504.","journal-title":"Blood"},{"key":"1520_CR37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.critrevonc.2012.02.005","volume":"83","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma. ALK-positive. Crit Rev Oncol Hematol. 2012;83:293\u2013302.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1520_CR38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","volume":"98","author":"I Oschlies","year":"2013","unstructured":"Oschlies I, Lisfeld J, Lamant L, Nakazawa A, d\u2019Amore ES, Hansson U, et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica. 2013;98:50\u20136.","journal-title":"Haematologica"},{"key":"1520_CR39","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1002\/pbc.24591","volume":"60","author":"D Williams","year":"2013","unstructured":"Williams D, Mori T, Reiter A, Woessman W, Rosolen A, Wrobel G, et al. Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study. Pediatr Blood Cancer. 2013;60:E118\u201321.","journal-title":"Pediatr Blood Cancer"},{"key":"1520_CR40","first-page":"317","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"DY Mason","year":"2008","unstructured":"Mason DY, Harris NL, Delsol G, Stein H, Campo E, Kinney MC, et al. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 317\u20139."},{"key":"1520_CR41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.critrevonc.2012.06.004","volume":"85","author":"AJ Ferreri","year":"2013","unstructured":"Ferreri AJ, Govi S, Pileri SA, Savage KJ. Anaplastic large cell lymphoma. ALK-negative. Crit Rev Oncol Hematol. 2013;85:206\u201315.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1520_CR42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","volume":"23","author":"AL Feldman","year":"2010","unstructured":"Feldman AL, Law ME, Inwards DJ, Dogan A, McClure RF, Macon WR. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus. Mod Pathol. 2010;23:593\u2013602.","journal-title":"Mod Pathol"},{"key":"1520_CR43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","volume":"28","author":"R Piva","year":"2010","unstructured":"Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I, et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010;28:1583\u201390.","journal-title":"J Clin Oncol"},{"key":"1520_CR44","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","volume":"120","author":"L Agnelli","year":"2012","unstructured":"Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E, et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood. 2012;120:1274\u201381.","journal-title":"Blood"},{"key":"1520_CR45","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","volume":"122","author":"C Liu","year":"2013","unstructured":"Liu C, Iqbal J, Teruya-Feldstein J, Shen Y, Dabrowska MJ, Dybkaer K, et al. MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood. 2013;122:2083\u201392.","journal-title":"Blood"},{"key":"1520_CR46","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","volume":"117","author":"AL Feldman","year":"2011","unstructured":"Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 2011;117:915\u20139.","journal-title":"Blood"},{"key":"1520_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAI.0b013e318266476c","volume":"21","author":"CR Taylor","year":"2013","unstructured":"Taylor CR, Siddiqi IN, Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol. 2013;21:13\u201320.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1520_CR48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1634\/theoncologist.2012-0238","volume":"18","author":"SK Story","year":"2013","unstructured":"Story SK, Schowalter MK, Geskin LJ. Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders. Oncologist. 2013;18:301\u20137.","journal-title":"Oncologist"},{"key":"1520_CR49","first-page":"1631","volume":"6","author":"EV George","year":"2013","unstructured":"George EV, Pharm J, Houston C, Al-Quran S, Brian G, Dong H, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol. 2013;6:1631\u201342.","journal-title":"Int J Clin Exp Pathol"},{"key":"1520_CR50","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0b013e31825749b1","volume":"36","author":"TN Aladily","year":"2012","unstructured":"Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012;36:1000\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2559.2003.01659.x","volume":"43","author":"S Kohno","year":"2003","unstructured":"Kohno S, Ohshima K, Yoneda S, Kodama T, Shirakusa T, Kikuchi M. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology. 2003;43:135\u201343.","journal-title":"Histopathology"},{"key":"1520_CR52","first-page":"445","volume":"33","author":"D Yang","year":"2004","unstructured":"Yang D, Bae C, Xio Y, Chen J. Clinicopathological analysis of primary intestinal non-Hodgkin\u2019s lymphoma: a report of 32 cases. Zhonghua Bing Li Xue Za Zhi. 2004;33:445\u20138.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"1520_CR53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12032-010-9783-x","volume":"29","author":"HF Gou","year":"2012","unstructured":"Gou HF, Zang J, Jiang M, Yang Y, Cao D, Chen XC. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma. Med Oncol. 2012;29:227\u201334.","journal-title":"Med Oncol"},{"key":"1520_CR54","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1471-2407-11-321","volume":"11","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer. 2011;11:321.","journal-title":"BMC Cancer"},{"key":"1520_CR55","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2011.45","volume":"24","author":"J Sun","year":"2011","unstructured":"Sun J, Lu Z, Yang D, Chen J. Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol. 2011;24:983\u201392.","journal-title":"Mod Pathol"},{"key":"1520_CR56","first-page":"289","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"PG Isaacson","year":"2008","unstructured":"Isaacson PG, Chott A, Ott G, Stein H. Enteropathy-associated T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 289\u201391."},{"key":"1520_CR57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","volume":"118","author":"J Delabie","year":"2011","unstructured":"Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011;118:148\u201355.","journal-title":"Blood"},{"key":"1520_CR58","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.humpath.2009.11.020","volume":"41","author":"YH Ko","year":"2010","unstructured":"Ko YH, Karnan S, Kim KM, Park CK, Kang ES, Kim YH, et al. Enteropathy-associated T-cell lymphoma\u2013a clinicopathologic and array comparative genomic hybridization study. Hum Pathol. 2010;41:1231\u20137.","journal-title":"Hum Pathol"},{"key":"1520_CR59","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","volume":"35","author":"JK Chan","year":"2011","unstructured":"Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, Lui YH, et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol. 2011;35:1557\u201369.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2559.2011.03768.x","volume":"58","author":"M Takeshita","year":"2011","unstructured":"Takeshita M, Nakamura S, Kikuma K, Nakayama Y, Nimura S, Yao T, et al. Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan. Histopathology. 2011;58:395\u2013407.","journal-title":"Histopathology"},{"key":"1520_CR61","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","volume":"27","author":"SY Tan","year":"2013","unstructured":"Tan SY, Chuang SS, Tang T, Tan L, Ko YH, Chuah KL, et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype. Leukemia. 2013;27:1688\u201396.","journal-title":"Leukemia"},{"key":"1520_CR62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-065X.2006.00475.x","volume":"215","author":"J Kunisawa","year":"2007","unstructured":"Kunisawa J, Takahashi I, Kiyono H. Intraepithelial lymphocytes: their shared and divergent immunological behaviors in the small and large intestine. Immunol Rev. 2007;215:136\u201353.","journal-title":"Immunol Rev"},{"key":"1520_CR63","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","volume":"117","author":"A Mansoor","year":"2011","unstructured":"Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117:1447\u201352.","journal-title":"Blood"},{"key":"1520_CR64","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","volume":"116","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K, et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116:5631\u20137.","journal-title":"Blood"},{"key":"1520_CR65","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","volume":"122","author":"AM Perry","year":"2013","unstructured":"Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013;122:3599\u2013606.","journal-title":"Blood"},{"key":"1520_CR66","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","volume":"92","author":"FD Groves","year":"2000","unstructured":"Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92:1240\u201351.","journal-title":"J Natl Cancer Inst"},{"key":"1520_CR67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2230.2012.04461.x","volume":"38","author":"JH Lee","year":"2013","unstructured":"Lee JH, Lee JH, Yoo DS, Kang H, Kim GM, Park HJ, et al. Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea. Clin Exp Dermatol. 2013;38:457\u201363.","journal-title":"Clin Exp Dermatol"},{"key":"1520_CR68","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jaad.2012.02.033","volume":"67","author":"JH Park","year":"2012","unstructured":"Park JH, Shin HT, Lee DY, Lee JH, Yang JM, Jang KT, et al. World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution. J Am Acad Dermatol. 2012;67:1200\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"1520_CR69","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1346-8138.2010.01049.x","volume":"38","author":"A Fujita","year":"2011","unstructured":"Fujita A, Hamada T, Iwatsuki K. Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008. J Dermatol. 2011;38:524\u201330.","journal-title":"J Dermatol"},{"key":"1520_CR70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0560.2006.00460.x","volume":"33","author":"K Yasukawa","year":"2006","unstructured":"Yasukawa K, Kato N, Kodama K, Hamasaka A, Hata H. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification. J Cutan Pathol. 2006;33:487\u201391.","journal-title":"J Cutan Pathol"},{"key":"1520_CR71","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064\u201373.","journal-title":"Blood"},{"key":"1520_CR72","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768\u201385.","journal-title":"Blood"},{"key":"1520_CR73","first-page":"302","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"P Gaulard","year":"2008","unstructured":"Gaulard P, Berti E, Willemze R, Jaffe ES. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 302\u20135."},{"key":"1520_CR74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","volume":"37","author":"SM Rodriguez-Pinilla","year":"2013","unstructured":"Rodriguez-Pinilla SM, Ortiz-Romero PL, Monsalvez V, Tomas IE, Almagro M, Sevilla A, et al. TCR-gamma expression in primary cutaneous T-cell lymphomas. Am J Surg Pathol. 2013;37:375\u201384.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR75","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/PAS.0b013e31822067d1","volume":"35","author":"A Garcia-Herrera","year":"2011","unstructured":"Garcia-Herrera A, Song JY, Chuang SS, Villamor N, Colomo L, Pittaluga S, et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol. 2011;35:1214\u201325.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR76","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cancergen.2012.05.006","volume":"205","author":"M Yamamoto-Sugitani","year":"2012","unstructured":"Yamamoto-Sugitani M, Kuroda J, Shimura Y, Nagoshi H, Chinen Y, Ohshiro M, et al. Comprehensive cytogenetic study of primary cutaneous gamma-delta T-cell lymphoma by means of spectral karyotyping and genome-wide single nucleotide polymorphism array. Cancer Genet. 2012;205:459\u201364.","journal-title":"Cancer Genet"},{"key":"1520_CR77","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","volume":"67","author":"A Nofal","year":"2012","unstructured":"Nofal A, Abdel-Mawla MY, Assaf M, Salah E. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation. J Am Acad Dermatol. 2012;67:748\u201359.","journal-title":"J Am Acad Dermatol"},{"key":"1520_CR78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1349-7006.2008.01000.x","volume":"100","author":"M Hagiwara","year":"2009","unstructured":"Hagiwara M, Takata K, Shimoyama Y, Yamamoto K, Takahashi E, Asano N, et al. Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: clinicopathological analysis of 27 patients. Cancer Sci. 2009;100:33\u201341.","journal-title":"Cancer Sci"},{"key":"1520_CR79","unstructured":"Gomez Vazquez M, Navarra Amayuelas R. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma? Dermatol Online J. 2012;18:11."},{"key":"1520_CR80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","volume":"31","author":"H Beltraminelli","year":"2009","unstructured":"Beltraminelli H, Leinweber B, Kerl H, Cerroni L. Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol. 2009;31:317\u201322.","journal-title":"Am J Dermatopathol"},{"key":"1520_CR81","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","volume":"21","author":"KL Grogg","year":"2008","unstructured":"Grogg KL, Jung S, Erickson LA, McClure RF, Dogan A. Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. 2008;21:708\u201315.","journal-title":"Mod Pathol"},{"key":"1520_CR82","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1309\/AJCP83AOQTMLOJTM","volume":"139","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L, Jansen PM, Kinney MC, Swerdlow SH, Willemze R. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop. Am J Clin Pathol. 2013;139:491\u2013514.","journal-title":"Am J Clin Pathol"},{"key":"1520_CR83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","volume":"33","author":"SM Rodriguez Pinilla","year":"2009","unstructured":"Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL, Mollejo M, Garcia JF, Montes-Moreno S, et al. Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol. 2009;33:81\u201390.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR84","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","volume":"36","author":"F Cetinozman","year":"2012","unstructured":"Cetinozman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol. 2012;36:109\u201316.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR85","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3346\/jkms.2008.23.2.185","volume":"23","author":"EY Cho","year":"2008","unstructured":"Cho EY, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH. The spectrum of Epstein\u2013Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. J Korean Med Sci. 2008;23:185\u201392.","journal-title":"J Korean Med Sci"},{"key":"1520_CR86","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","volume":"17","author":"SB Ng","year":"2004","unstructured":"Ng SB, Lai KW, Murugaya S, Lee KM, Loong SL, Fook-Chong S, et al. Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004;17:1097\u2013107.","journal-title":"Mod Pathol"},{"key":"1520_CR87","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","volume":"36","author":"T Pongpruttipan","year":"2012","unstructured":"Pongpruttipan T, Sukpanichnant S, Assanasen T, Wannakrairot P, Boonsakan P, Kanoksil W, et al. Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta\/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36:481\u201399.","journal-title":"Am J Surg Pathol"},{"key":"1520_CR88","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","volume":"118","author":"K Karube","year":"2011","unstructured":"Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood. 2011;118:3195\u2013204.","journal-title":"Blood"},{"key":"1520_CR89","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.2823","volume":"223","author":"SB Ng","year":"2011","unstructured":"Ng SB, Selvarajan V, Huang G, Zhou J, Feldman AL, Law M, et al. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK\/T cell lymphoma revealed by gene expression profiling. J Pathol. 2011;223:496\u2013510.","journal-title":"J Pathol"},{"key":"1520_CR90","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","volume":"25","author":"J Iqbal","year":"2011","unstructured":"Iqbal J, Weisenburger DD, Chowdhury A, Tsai MY, Srivastava G, Greiner TC, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 2011;25:348\u201358.","journal-title":"Leukemia"},{"key":"1520_CR91","first-page":"278","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"L Quintanilla-Martinez","year":"2008","unstructured":"Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. p. 278\u201380."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1520-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1520-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1520-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T18:02:15Z","timestamp":1648144935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1520-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1520"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1520-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,31]]}}}